Cargando…
Visfatin/PBEF/Nampt: A New Cardiovascular Target?
In the last years, a growing interest has emerged toward understanding the role of adipocytokines in the development of cardio-metabolic complications. Five years ago, visfatin/PBEF/Nampt was identified as a novel adipocytokine. In the context of metabolic disorders, extracellular visfatin/PBEF/Namp...
Autores principales: | Peiró, Concepción, Romacho, Tania, Carraro, Raffaele, Sánchez-Ferrer, Carlos F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153009/ https://www.ncbi.nlm.nih.gov/pubmed/21833174 http://dx.doi.org/10.3389/fphar.2010.00135 |
Ejemplares similares
-
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013) -
Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans
por: Hallschmid, Manfred, et al.
Publicado: (2009) -
Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
por: Romacho, Tania, et al.
Publicado: (2013) -
Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions
por: Kaja, Simon, et al.
Publicado: (2015) -
Do monocytes use the novel adipocytokine Visfatin/NAMPT/PBEF1 to flip the HIV coreceptor switch?
por: Bergh, Rafael Van den, et al.
Publicado: (2009)